Drug Shortage Report for AVAPRO
| Report ID | 139790 |
| Drug Identification Number | 02237923 |
| Brand name | AVAPRO |
| Common or Proper name | Avapro |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | IRBESARTAN |
| Strength(s) | 75MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 90 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2021-05-21 |
| Estimated end date | 2021-08-02 |
| Actual end date | 2021-06-18 |
| Shortage status | Resolved |
| Updated date | 2021-06-19 |
| Company comments | Delay in testing. Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: [email protected] Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-06-19 | English | Compare |
| v5 | 2021-06-18 | French | Compare |
| v4 | 2021-06-18 | English | Compare |
| v3 | 2021-05-22 | English | Compare |
| v2 | 2021-05-21 | French | Compare |
| v1 | 2021-05-21 | English | Compare |
Showing 1 to 6 of 6